The first appointment for most clinical studies takes 2-3 hours minimum due to ensuring you meet the diagnosis requirements to participate in the study.

Patient stipend amounts vary depending on what study you enroll in. Contact us at 314-849-1853 for information on each study.

We'll do a prescreening log to determine inclusion and exclusion criteria. If you qualify for the study, we will schedule an appointment based on your availability. A study coordinator will share all study and visit information depending on the study you are participating in and will let you know what to expect on your first visit.

There is no cost to participate in a research study. Patients will receive a stipend from a sponsor for their participation.

We are in HIPPA compliance and only share the data from your trial with our sponsors after we receive your consent.

Participants have the right to withdraw at any time throughout the study.

PCCR current clinical trial sponsors are Livanova, Karuna, Neurocrine, Otsuka, Teva, Ceravel, Boehringer Ingelheim, Sunovion, Roche, Janssen, Biohaven, Corrona, Vanda, Orca, and Indivior. Patient stipends are sponsored by the prospective study sponsors and varies depending on the study you enroll in.

Clinical research is the comprehensive study of the safety, effectiveness and side effects of drugs, device, vaccine and diagnostic test for patient care. Clinical research involves people who volunteer to help us better understand medicine and health. They are 4 phases of clinical research trial to learn about the safety, effectiveness and side effects.

There are 3 main phases of clinical trials – phases 1 to 3. Phase 1 trials are the earliest phase trials and phase 3 are later phase trials. Some trials have an earlier stage called phase 0 for animal studies, and there are some phase 4 trials done after a drug has been licensed. Some trials are randomised. PsychCARE Consultants Research performs phase 2 and phase 3 clinical trials. Phase 2 clinical trials are performed with a small population that fits the study diagnosis area. Phase 3 trials are performed on a larger population with the study diagnosis area. The phases of all clinical trials are summarized below: Phase 0: Initial pharmacokinetic and pharmacodynamic assessment via microdosing. Phase 1: Small number of healthy volunteers or patients with disease of interest participate in the study for safety assessment. Phase 2: Moderate number of patients with disease of interest participate in the study for efficacy assessment to provide additional data on short-term adverse effects. Phase 3: Large number of patients randomized to study the effective assessment via comparison with placebo or current standard of care. Phase 4: Post-marketing surveillance of patients with disease of interest which provides data on long-term or rare adverse effects.

The clinical trials we conduct are phase 2 and phase 3 clinical trials for FDA approval. The data will be collected by sponsors.

We will have a pre-screen telephone call to see whether you meet the criteria for the study. Please call us any time at 314-852-2715 and we will be in touch within 2-3 business days to discuss qualification information. Visit our Current Studies page to see our ongoing studies and criteria for each.